Navigation Links
New Federal Training Grant to Teach Doctors/Scientists Immunology
Date:8/20/2009

The Schneider Children's Hospital (SCH) campus of The Feinstein Institute for Medical Research has been awarded a prestigious $795,000 federal grant to hire and train the next generation of immunologists who will investigate diseases of the immune system to provide cutting-edge care to patients.

Manhasset, NY (Vocus) August 20, 2009 -- The Schneider Children's Hospital (SCH) campus of The Feinstein Institute for Medical Research has been awarded a prestigious $795,000 federal grant to hire and train the next generation of immunologists who will investigate diseases of the immune system to provide cutting-edge care to patients.

The new federal "T32" training grant, to be funded over the next five years by the National Institute for Allergy and Infectious Diseases, will allow Vincent Bonagura, MD, chief of pediatric immunology at SCH and a researcher at the Feinstein Institute, to train physicians to understand the basic immunobiology of the immune system and how it is involved in causing or preventing a myriad of diseases.
   
"This T32 grant, the first ever received by the North Shore-LIJ Health System, is significant because it's a national recognition of the major clinical and research expertise that Schneider Children's Hospital and the Feinstein Institute have in the area of immunology," said Arthur Klein, MD, senior vice president of children's services for the North Shore-LIJ Health System, and the executive director and chief of staff at SCH.
   
Physician/scientists selected for the new program will be able to spend time in any of the Feinstein Institute's various immunology labs. "They will have access to pediatric and adult patients who receive care for immunology-related diseases at Schneider Children's Hospital, North Shore University Hospital and LIJ Medical Center, along with patients cared for in other subspecialties that are related by the common language of immunology," said Dr. Bonagura. He added that there are an increasing number of immune-related disciplines -- including allergy, rheumatology, infectious diseases, cancers and autoimmune diseases -- that are in need of physicians and scientists trained in basic-science immunology who can expand our knowledge of the immune pathogenesis of these diseases, and provide novel and more effective therapies to treat patients.
   
"We need to train true academic doctors who will be able to advance the field," said Dr. Bonagura. The physician/scientist can also extend their training by applying for a fourth year within the Elmezzi Graduate School of Molecular Medicine (www.elmezzigraduateschool.org). The graduate school, part of the Feinstein Institute and the North Shore-LIJ Health System, trains physicians interested in becoming scientists as well. At the end of three years of training in the immunology physician/scientist program, students can earn a PhD degree in molecular medicine by completing a fourth year in the program.

Candidates for the immunology physician scientist training program will be drawn from a yearly complement of more than 110 pediatricians and internists applying for fellowship training in Allergy and Immunology Residency Training Program at Schneider Children's Hospital and LIJ Medical Center.
   
In addition to being chief of the Division of Allergy and Immunology at Schneider Children's Hospital, Dr. Bonagura is associate chair of pediatrics at SCH, and is currently a director of the American Board of Allergy and Immunology and Member of the American Board of Pediatrics. Betty Diamond, MD, director of the Feinstein's Center for Autoimmune and Musculoskeletal Diseases will be the co-director of the T32 Immunology Physician Scientist program. Dr. Diamond is an expert on rheumatic diseases, and focuses her attention on the brain problems associated with lupus.
   
The federal training grant fits with the mission of the Feinstein to discover and understand the causes and underlying mechanisms of human diseases, and to rapidly translate this information into diagnostic and therapeutic solutions for patients. Dr. Bonagura's lab focuses on human host defense mechanisms made against human papillomaviruses.

Contact
Jamie Talan
Science writer-in-residence
516-562-1232 (w) or 631-682-8781 (c)

###

Read the full story at http://www.prweb.com/releases/Feinstein_Institute/Allergy_Immunology/prweb2772464.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. MDMA Names New Director of Federal Affairs
2. Federal research plan to determine nanotech risks fails to deliver
3. Federal Employee Program Maintains Low Health Premiums In 2008
4. AMERIGROUP Contracts with Federal Government to Offer Medicare Advantage Health Plans in Seven States
5. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
6. ACM Helps Medicaid Programs Comply With Federal Deficit Reduction Act Mandates
7. Boise(R) BEWARE(TM) Meets New Federal Guidelines Set Forth by Medicaid
8. HIV/AIDS Cases Among State and Federal Prison Inmates Fell for the Sixth Straight Year During 2005
9. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
10. Federal Trade Commission Attempts To Suppress Best-Selling Authors First Amendment Rights
11. CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Federal Training Grant to Teach Doctors/Scientists Immunology
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: ... networking and recognition opportunities as well as advocacy for the state and region‘s ... on February 23. The Council's Innovation Forecast event highlights innovation throughout the ...
(Date:2/24/2017)... ... , ... With millions of Americans and people worldwide struggling ... are aware of our options and are empowered with strength and information throughout ... its newest edition of "Vision and Hearing" in USA Today, that will educate ...
(Date:2/24/2017)... , ... February 24, 2017 , ... Yisrayl Hawkins, Pastor ... on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement when ... generation. He explains that the Bible details the current times so plainly that ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to ... Elite division on February 12th. Ms. Esparza qualified into this prestigious status ... competition held in Las Vegas, Nevada. Frida is one of approximately 25 gymnasts ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... the La Gorce Country Club in Miami Beach to host its Swirl: Miami ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... YORK , Feb. 23, 2017  The ... 330.6 million by 2021 from USD 275.9 million ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... increasing spending on pharmaceutical R&D, and growth in ... driving the market growth for particle counters. On ...
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... provides drug pricing data and benchmarks in the global Autism Spectrum ... What are the key drugs marketed for Autism ...
(Date:2/23/2017)... CITY, Calif., Feb. 23, 2017 Nevro Corp. (NYSE: ... evidence-based solutions for the treatment of chronic pain, today reported ... December 31, 2016. 2016 Accomplishment & Highlights: ... full year 2016, an increase of 228% as reported, over ... for 2016, an increase of 612% over the prior year ...
Breaking Medicine Technology: